AstraZeneca PLC Share Price Berne S.E.
Stocks
000982352
GB0009895292
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Berne S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 135.15 CHF | +2.81% |
|
+2.97% | -6.70% |
| 03:56am | AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah | MT |
| 05/09 | FDA Approves AstraZeneca Treatment for Advanced Breast Cancer -- Update | DJ |
| Market Cap | 25TCr 22TCr 20TCr 19TCr 35TCr 23,78900Cr 35TCr 2,40800Cr 94TCr 12,19400Cr 95TCr 92TCr 39,33400Cr | P/E 2026 * |
20.9x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 27TCr 23TCr 22TCr 20TCr 38TCr 25,62800Cr 38TCr 2,59500Cr 1,00700Cr 13,13700Cr 1,01800Cr 1LCr 42,37500Cr | EV / Sales 2026 * |
4.29x | EV / Sales 2027 * | 3.94x |
| Free-Float |
96.63% | Yield 2026 * |
2.06% | Yield 2027 * | 2.19% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript : AstraZeneca PLC
| 1 day | +2.81% | ||
| 1 week | +2.97% | ||
| Current month | +1.84% | ||
| 1 month | +7.83% | ||
| 3 months | -1.36% | ||
| 6 months | -11.24% | ||
| Current year | -6.70% |
| 1 week | 131.45 |  | 135.15 |
| 1 month | 124.91 | | 135.15 |
| Current year | 124.91 | | 163 |
| 1 year | 116.75 | | 163 |
| 3 years | 104.86 | | 163 |
| 5 years | 95 | | 163 |
| 10 years | 52.7 | | 163 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.81% | +2.97% | - | - | 26TCr | |
| -0.88% | -2.27% | +55.78% | +106.31% | 1,03400Cr | |
| -1.15% | +3.56% | +54.62% | +71.50% | 67TCr | |
| -1.44% | -0.65% | +21.05% | +73.05% | 46TCr | |
| +0.14% | -1.92% | +32.47% | +37.60% | 35TCr | |
| -1.33% | +3.96% | +25.71% | +45.03% | 31TCr | |
| -1.15% | -0.89% | -1.67% | +12.21% | 26TCr | |
| -1.55% | +0.05% | +54.04% | +70.32% | 24TCr | |
| -0.88% | +1.24% | -18.03% | -54.06% | 21TCr | |
| -0.15% | +1.43% | +33.64% | +96.99% | 19TCr | |
| Average | -0.08% | +1.27% | +28.62% | +50.99% | 41.3TCr | |
| Weighted average by Cap. | +0.00% | +1.04% | +37.27% | +66.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.32TCr 5.45TCr 5.12TCr 4.68TCr 8.75TCr 5,97600Cr 8.78TCr 61TCr 23TCr 3,06300Cr 24TCr 23TCr 9,88100Cr | 6.69TCr 5.76TCr 5.41TCr 4.94TCr 9.25TCr 6,31600Cr 9.28TCr 64TCr 25TCr 3,23800Cr 25TCr 25TCr 10,44400Cr |
| Net income | 1.2TCr 1.03TCr 972.25Cr 888.83Cr 1.66TCr 1,13500Cr 1.67TCr 11TCr 4.46TCr 58TCr 4.51TCr 4.41TCr 1,87700Cr | 1.37TCr 1.18TCr 1.11TCr 1.01TCr 1.9TCr 1,29400Cr 1.9TCr 13TCr 5.09TCr 66TCr 5.14TCr 5.03TCr 2,14000Cr |
| Net Debt | 1.95TCr 1.68TCr 1.57TCr 1.44TCr 2.69TCr 1,83900Cr 2.7TCr 19TCr 7.23TCr 94TCr 7.31TCr 7.15TCr 3,04000Cr | 1.18TCr 1.02TCr 953.68Cr 871.86Cr 1.63TCr 1,11400Cr 1.64TCr 11TCr 4.38TCr 57TCr 4.43TCr 4.33TCr 1,84200Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | CHF 135.15 | +2.81% | 45 |
| 02/26/02 | CHF 131.45 | -0.95% | 24 |
| 31/26/31 | CHF 132.71 | +0.36% | 41 |
| 28/26/28 | CHF 132.24 | +0.75% | 1 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
Select your edition
All financial news and data tailored to specific country editions
